BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25231080)

  • 1. Strong YB-1 expression predicts liver recurrence following resection for colorectal metastases.
    Ardito F; Arena V; Vellone M; Grande G; Pennacchia I; Majellaro F; Giovannini I; Vecchio FM; Nuzzo G; Giuliante F
    J Gastrointest Surg; 2014 Nov; 18(11):1987-93. PubMed ID: 25231080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Fbxw7 expression is a predictor of recurrence in colorectal liver metastasis.
    Kawashita Y; Morine Y; Ikemoto T; Saito Y; Iwahashi S; Yamada S; Higashijima J; Imura S; Ogawa H; Yagi T; Shimada M
    J Hepatobiliary Pancreat Sci; 2017 Oct; 24(10):576-583. PubMed ID: 28846828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
    Wiggans MG; Shahtahmassebi G; Aroori S; Bowles MJ; Briggs C; Stell DA
    Eur J Surg Oncol; 2016 Mar; 42(3):426-32. PubMed ID: 26821736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal liver metastases: hepatic pedicle clamping during hepatectomy reduces the incidence of tumor recurrence in selected patients. Case-matched analysis.
    De Carlis L; Di Sandro S; Giacomoni A; Mihaylov P; Lauterio A; Mangoni I; Cusumano C; Poli C; Tripepi M; Bencardino K
    Eur J Surg Oncol; 2013 Jul; 39(7):726-33. PubMed ID: 23601983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear Y-Box-binding Protein-1 Expression Predicts Poor Clinical Outcome in Stage III Colorectal Cancer.
    Shiraiwa S; Kinugasa T; Kawahara A; Mizobe T; Ohchi T; Yuge K; Fujino S; Katagiri M; Shimomura S; Tajiri K; Sudo T; Kage M; Kuwano M; Akagi Y
    Anticancer Res; 2016 Jul; 36(7):3781-8. PubMed ID: 27354655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated mTOR expression as a predictor of survival after liver resection for colorectal liver metastases.
    Konishi T; Yoshidome H; Shida T; Furukawa K; Takayashiki T; Kuboki S; Takano S; Miyazaki M; Ohtsuka M
    J Surg Oncol; 2021 Sep; 124(4):598-606. PubMed ID: 34061356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
    Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of laparoscopic versus open liver resection for liver metastases from colorectal cancer: A comparative analysis of 168 consecutive cases at a single center.
    Hasegawa Y; Nitta H; Sasaki A; Takahara T; Itabashi H; Katagiri H; Otsuka K; Nishizuka S; Wakabayashi G
    Surgery; 2015 Jun; 157(6):1065-72. PubMed ID: 25791030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat hepatic resection in patients with colorectal liver metastases.
    Lee H; Choi SH; Cho YB; Yun SH; Kim HC; Lee WY; Heo JS; Choi DW; Jung KU; Chun HK
    World J Gastroenterol; 2015 Feb; 21(7):2124-30. PubMed ID: 25717247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases.
    Yamada H; Kondo S; Okushiba S; Morikawa T; Katoh H
    World J Surg; 2001 Sep; 25(9):1129-33. PubMed ID: 11571947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer Metastases.
    Kaltenmeier C; Morocco B; Yazdani H; Reitz K; Meyer K; Molinari M; Geller D; Tohme S
    Am Surg; 2021 Nov; 87(11):1766-1774. PubMed ID: 34766506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver metastases from gastric cancer represent systemic disease in comparison with those from colorectal cancer.
    Oguro S; Imamura H; Yoshimoto J; Ishizaki Y; Kawasaki S
    J Hepatobiliary Pancreat Sci; 2016 Jun; 23(6):324-32. PubMed ID: 26946472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
    Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
    Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weak stromal Caveolin-1 expression in colorectal liver metastases predicts poor prognosis after hepatectomy for liver-only colorectal metastases.
    Neofytou K; Pikoulis E; Petrou A; Agrogiannis G; Petrides C; Papakonstandinou I; Papalambros A; Aggelou A; Kavatzas N; Liakakos T; Felekouras E
    Sci Rep; 2017 May; 7(1):2058. PubMed ID: 28515480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis.
    Bredt LC; Rachid AF
    World J Surg Oncol; 2014 Dec; 12():391. PubMed ID: 25528650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
    Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y
    Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases.
    Lang H; Baumgart J; Heinrich S; Tripke V; Passalaqua M; Maderer A; Galle PR; Roth W; Kloth M; Moehler M
    Ann Surg; 2019 Nov; 270(5):799-805. PubMed ID: 31634180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival.
    Höppener DJ; Nierop PMH; van Amerongen MJ; Olthof PB; Galjart B; van Gulik TM; de Wilt JHW; Grünhagen DJ; Rahbari NN; Verhoef C
    Ann Surg Oncol; 2019 Sep; 26(9):2812-2820. PubMed ID: 31147988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.